← Back to headlines
Novartis' Rhapsido Skin Disease Drug Approved by European Commission
Novartis has secured approval from the European Commission for its new drug, Rhapsido, intended for the treatment of skin diseases.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
